About Mogito Open Access Journals Of Clinical Trials & Therapeutics (MJCTT)

MJCTT

Editorial Board

Publication Ethics

Editorial Policy

Authors Guide

MJCTT bridges the gap between scientific discovery and patient-centered care by providing a transparent and inclusive platform for the design, execution, analysis, and reporting of clinical trials. We focus on studies that not only test interventions but also challenge conventions, explore new methodologies, and promote global collaboration.

Unlike conventional journals, MJCTT is:

• Ethics-first in approach, quality-first in content

• Focused on the future of medicine — from molecules to mechanisms to markets

• Open to voices from all clinical and cultural contexts

• Built for real-world therapeutic impact — not just academic citation

Where Research Meets Real-World Therapeutics

Aims and Scope

MJCTT welcomes original clinical trial reports, protocols, therapeutic analyses, real-world evidence studies, translational research, and meta-research on trial design across:

• Pharmacologic & Biologic Therapies

• Medical Devices & Digital Therapeutics

• Oncology & Immunotherapy Trials

• Infectious Disease & Vaccine Trials

• Rare Disease & Orphan Drug Research

• Psychiatric & Neurological Therapeutics

• Global & Community-Based Clinical Research

• Precision & Personalized Medicine Approaches

• Post-marketing Surveillance & Pharmacovigilance

• Adaptive & Pragmatic Trial Designs

Our Mission

At MJCTT, our mission is to redefine how clinical trials are communicated and consumed. We believe that therapeutics evolve not only in the lab but also in policy, in practice, and in partnership with patients.

Our goal is to:

• Promote transparent, reproducible, and ethically sound research

• Empower researchers in low- and middle-income countries to contribute to global science

• Accelerate access to life-changing therapies by making evidence openly accessible

Open Access, Licensing & Ethics

MJCTT is published under the Creative Commons Attribution License (CC BY 4.0), ensuring that all content is freely available to the public, while authors retain full copyright. We strictly adhere to ICMJE, CONSORT, and COPE guidelines.

Our Editorial Vision

Led by a global team of clinician-researchers, statisticians, bioethicists, and policy experts, MJCTT’s editorial board is dedicated to:

• Upholding rigorous peer review and scientific transparency

• Encouraging multidisciplinary and patient-engaged research

• Supporting early-career scientists and emerging research groups

• Publishing novel trial methodologies and disruptive therapeutic insights

MJCTT stands out by publishing not only results, but also:

• Trial protocols and design rationale

• Negative results and trial failures

• Pre-registration and open peer-review reports

Indexing & Discoverability (In Progress)

MJCTT is working toward inclusion in DOAJ, PubMed Central, Scopus, and Google Scholar, ensuring our authors’ work is discoverable, citable, and widely disseminated.

Partner with Us

Whether you’re developing a first-in-human therapy, coordinating a global multicenter trial, or rethinking how outcomes are measured, MJCTT welcomes your voice.

Join us as an author, editor, reviewer, or collaborator and help advance the next generation of therapeutic discovery.

Submit your manuscript: [mjctt@mogitojournals.org]
Contact the editorial office: editors_mjctt@mogitojournals.org

Contact Us – Enquiries & More Information

Thank you for your interest in the Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT). For general enquiries, submission guidance, editorial questions, or partnership opportunities, please complete the form below. A member of our team will get back to you promptly.

Email

editors_mjctt@mogitojournals.org

About Mogito Open Access Journals

We are a global publisher dedicated to the unrestricted dissemination of peer-reviewed scientific research across diverse disciplines, fostering collaboration and accessibility for authors and readers worldwide.

Mogito Energy International Ltd

We are pleased to inform our users that Mogito Open Access Journals operates as an official academic publishing division under Mogito Energy International Ltd. This integration reflects our commitment to advancing scientific knowledge, innovation, and cross-disciplinary research within a globally recognized corporate framework.